vTv Therapeutics (VTVT) Interest Expenses (2014 - 2026)
vTv Therapeutics (VTVT) posted Interest Expenses of $20.7 million for Q1 2026, up 10531.28% sequentially from $195000.0 in Q4 2025, and up 15970.54% YoY from N/an in Q1 2025.
vTv Therapeutics (VTVT) Interest Expenses (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported Interest Expenses for 13 years, with the latest figure at $20.7 million in Q1 2026.
- Quarterly Interest Expenses rose 15970.54% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.7 million (up 15970.54% YoY) and the FY2025 annual result came in at $50.1 million, up 47.31% from the prior year.
- Interest Expenses advanced to $20.7 million in Q1 2026 per VTVT's latest filing, from $195000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $20.7 million in Q1 2026 and troughed at $2000.0 in Q4 2024.
- A 5-year average of $1.7 million and a median of $274000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses tumbled 97.78% in 2025, then surged 15970.54% in 2026.
- Over 5 years, Interest Expenses stood at $6000.0 in 2022, then rose by 16.67% to $7000.0 in 2023, then sank by 71.43% to $2000.0 in 2024, then surged by 9650.0% to $195000.0 in 2025, then surged by 10531.28% to $20.7 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $20.7 million, $195000.0, and $5000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | 17.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.86 Mn |
| Jun 30, 2026 | 17.86 Mn |
| Mar 31, 2026 | 20.73 Mn |
| Mar 31, 2026 | 20.73 Mn |
| Dec 31, 2025 | 195,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 225,000.00 |
| Sep 30, 2024 | 225,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Mar 31, 2024 | 322,000.00 |
| Mar 31, 2024 | 322,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |